structure. Conclusion. ODF therapy with
methyluracil and
6-methyl-3-(thietan-3-yl)uracil leads
Kataev, V.A.,
Petrova, S.F.,
Perfilova, V.N.,
Murinov, Y.I.,
Bashkatov, S.A.,
Ivanov, S.P.,
Kataev, V.V.,
Agletdinov, E.F. (2021) , glycyrrhizic acid, and
methyluracil (LGM) possessing antiarrhythmic activity were studied. The FDF of LGM upon
Luo, W.,
Chen, X.,
Ye, L.,
Chen, X.,
Jia, W.,
Zhao, Y.,
Samorodov, A.V.,
Zhang, Y.,
Hu, X.,
Zhuang, F.,
Qian, J.,
Zheng, C.,
Liang, G.,
Wang, Y. (2021) of diabetic nephropathy (DN). TRAF
6 functions as a signal transducer in toll-like receptor 4 and NF-κB pro
Han, Z.B.,
Wang, X.X.,
Xu, Z.H.,
Cao, Y.,
Gong, R,
Zagidullin, N.,
Sukhareva, N.,
Zhang, Y. (2021) N-
6-methyladenosine (m(
6)A) RNA modification, a dynamic and reversible process, is essential
The synthesis and antimicrobial evaluation of new 2-[
6-methyl-4-(thietan-3-yloxy)pyrimidin-2-ylthio
Smirnova, L. A.,
Spasov, A. A.,
Khaliullin, F. A.,
Kucheryavenko, A. F.,
Ryabukha, A. F.,
Abramov, O. K. (2021) antiplatelet drug 3-methyl-8-(piperazin-1-yl)-7-(thietan-3-yl)-1-ethyl-1H-purine-2,
6(3H,7H)-dione hydrochloride